Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dysmetabolic Syndrome”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Study completedNCT00432276
What this trial is testing

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 803
Not applicableUnknownNCT06094036
What this trial is testing

Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism

Who this might be right for
Hypogonadism, MaleMetabolic SyndromeAutonomic Imbalance+2 more
Istituto Auxologico Italiano 72
Large-scale testing (Phase 3)Ended earlyNCT00762684
What this trial is testing

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 8
Not applicableStudy completedNCT05761145
What this trial is testing

Sphingo-lipotoxicity and Trans-differentiation of Adipose Tissue in Obesity (SFINGOTRANS)

Who this might be right for
ObesityHealthy
Istituto Auxologico Italiano 84
Post-approval studies (Phase 4)Study completedNCT00770835
What this trial is testing

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 39
Large-scale testing (Phase 3)Study completedNCT00286494
What this trial is testing

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 493
Large-scale testing (Phase 3)Study completedNCT00286442
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 527
Post-approval studies (Phase 4)Study completedNCT00304993
What this trial is testing

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

Who this might be right for
Metabolic Syndrome XInsulin Resistance
Foundation Research, Florida 30
Large-scale testing (Phase 3)Study completedNCT00655863
What this trial is testing

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus
Takeda 71
Large-scale testing (Phase 3)Ended earlyNCT00762957
What this trial is testing

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 15
Not applicableStudy completedNCT03453918
What this trial is testing

Effects of Polyphenols on Iron Absorption in Iron Overload Disorders.

Who this might be right for
Dysmetabolic Iron Overload SyndromeGenetic HemochromatosisIron Absorption+1 more
University Hospital, Clermont-Ferrand 41
Post-approval studies (Phase 4)Study completedNCT00494312
What this trial is testing

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Who this might be right for
Diabetes MellitusLiver
Takeda 2,120
Post-approval studies (Phase 4)Study completedNCT00770445
What this trial is testing

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 121
Not applicableUnknownNCT02066012
What this trial is testing

MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)

Who this might be right for
Dysmetabolic Iron Overload SyndromeMetabolic Syndrome X
University Hospital, Clermont-Ferrand 60
Large-scale testing (Phase 3)Study completedNCT00395512
What this trial is testing

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 655
Large-scale testing (Phase 3)Study completedNCT00707993
What this trial is testing

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Who this might be right for
Diabetes Mellitus
Takeda 441
Large-scale testing (Phase 3)Study completedNCT00286429
What this trial is testing

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus
Takeda 390
Testing effectiveness (Phase 2)Study completedNCT00676260
What this trial is testing

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Who this might be right for
Diabetes Mellitus
Takeda 29
Large-scale testing (Phase 3)Ended earlyNCT00521820
What this trial is testing

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Who this might be right for
Diabetes Mellitus
Takeda 518
Large-scale testing (Phase 3)Study completedNCT00772174
What this trial is testing

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 418
Next Page